Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 1—January 2023
Dispatch

COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA

Michael E. DeWittComments to Author , Ashley H. Tjaden, David Herrington, John Schieffelin, Michael Gibbs, William S. Weintraub, John W. Sanders1, Sharon L. Edelstein1, and on behalf of the COVID-19 Community Research Partnership
Author affiliations: Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA (M.E. DeWitt, D. Herrington, J.W. Sanders); The George Washington University Milken Institute of Public Health, Rockville, Maryland, USA (A.H. Tjaden, S.L. Edelstein); Tulane School of Medicine, New Orleans, Louisiana, USA (J.S. Schieffelin); Atrium Health, Charlotte, North Carolina, USA (M.A. Gibbs); MedStar Health, Columbia, Maryland, USA (W.S. Weintraub); Georgetown University, Washington, DC, USA (W.S. Weintraub)

Main Article

Figure 2

Reported COVID-19 symptoms by variant in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA. A) Proportion of symptomatic persons reporting symptoms; we defined a symptomatic episode as the presence of any new symptoms in the 14-day window, where new means not occurring in the 7 days preceding the first observation of the symptom within the window. B) Odds ratio of reporting a symptom by variant wave using Delta as the baseline. C) Average length of participant-reported symptom duration in a symptomatic infection. D) Difference in symptom duration from Delta-period infections. Error bars represent 95% CI.

Figure 2. Reported COVID-19 symptoms by variant in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA. A) Proportion of symptomatic persons reporting symptoms; we defined a symptomatic episode as the presence of any new symptoms in the 14-day window, where new means not occurring in the 7 days preceding the first observation of the symptom within the window. B) Odds ratio of reporting a symptom by variant wave using Delta as the baseline. C) Average length of participant-reported symptom duration in a symptomatic infection. D) Difference in symptom duration from Delta-period infections. Error bars represent 95% CI.

Main Article

1These senior authors contributed equally to this article.

Page created: December 09, 2022
Page updated: December 22, 2022
Page reviewed: December 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external